Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technivie + Ribavirin in HCV GT4
NCT04378608Phase 2Completed
- Sponsor
- Beni Suef University
- Start
- Jan 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ombitasvir + paritaprevir + ritonavir in hepatitis C (HCV), sponsored by Beni Suef University. Started Jan 2017; status: completed.
02
Drugs
ombitasvir + paritaprevir + ritonavir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT04378608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04378608.